Celgene
Celgene Corporation engages in the discovery, development, and commercialization of innovative therapies to treat cancer and immune-inflammatory related diseases primarily in Europe and the United States. Its primary commercial stage products...Founded in 1980
Homepage: http://www.celgene.com/
07901
86 Morris Avenue
Summit
USA NJ
Summit
USA NJ
Phone: 908-673-9000
Updated on Apr 4, 2013
Celgene at CrunchBase
Robert J. Hugin Chairman and Chief Executive OfficerCelgene at CrunchBase
Jacqualyn A. Fouse Executive Vice President and Chief Financial Officer
Perry A. Karsen Executive Vice President and Chief Operations Officer
Past
Sol J. Bare Chairman & CEO
David W. Gryska CFO
October, 2012
Celgene invested $35M in VentiRx Pharmaceuticals as unattributed round
February, 2012
Celgene invested $15M in Acetylon Pharmaceuticals as unattributed round
January, 2012
Celgene acquired Avila Therapeutics for $925M
Celgene to acquire Avila Therapeutics 
reuters.com
December, 2011
Celgene invested $30M in Acceleron Pharma as a Series F round
November, 2011
Celgene invested $78M in Agios Pharmaceuticals as a Series C round
June, 2010
Celgene acquired Abraxis BioScience for $2.9B
Celgene strikes $2.9B deal to acquire Abraxis 
fiercebiotech.com
Celgene invested $12M in FerroKin Biosciences as a Series B round
December, 2009
Celgene acquired Gloucester Pharmaceuticals for $640M
Gloucester Pharma selling for $640M to Celgene 
masshightech.com
1980
Celgene was founded in 1980